Showing results (71-80 of 808) with videos related to
Sort By:
Pageof 81
Journal of Hypertension|March 25, 2011
Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same classGiuseppe Mancia, Andrea Parodi, Luca Merlino, et al.Blood Pressure Monitoring|December 21, 2011
Masked hypertension and echocardiographic left ventricular hypertrophy: an updated overviewCesare Cuspidi, Francesca Negri, Carla Sala, et al.European Journal of Clinical Investigation|August 19, 2014
Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based studyGiovanni Corrao, Davide Soranna, Luca Merlino, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|July 7, 2020
COVID-19 and arterial hypertension: Hypothesis or evidence?Marijana Tadic, Cesare Cuspidi, Guido Grassi, et al.Circulation|July 5, 2012
Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on AtherosclerosisGiuseppe Mancia, Rita Facchetti, Gianfranco Parati, et al.Current Hypertension Reports|April 1, 2011
Sympathetic mechanisms, organ damage, and antihypertensive treatmentGuido Grassi, Gino Seravalle, Raffaella Dell'Oro, et al.Journal of Hypertension|April 14, 2012
Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatmentGiuseppe Mancia, Rita Facchetti, Gianfranco Parati, et al.Journal of Hypertension|July 26, 2022
Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian databaseLaura Savaré, Federico Rea, Giovanni Corrao, et al.Integrated Blood Pressure Control|May 6, 2020
Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?Marijana Tadic, Cesare Cuspidi, Guido Grassi, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 20, 2006
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?Tonje Amb Aksnes, Sverre Erik Kjeldsen, Giuseppe ManciaPageof 81